APA (7th ed.) Citation

N, F., M, M., A, P., JD, C., MJ, J., I, C., . . . J, R. (2025). Real-world evidence of nivolumab monotherapy in advanced renal cell carcinoma from a multicenter retrospective cohort study by the Spanish Genitourinary Oncology Group. BMC cancer, 25(1), 1835. https://doi.org/10.1186/s12885-025-15264-9

Chicago Style (17th ed.) Citation

N, Fernández-Díaz, et al. "Real-world Evidence of Nivolumab Monotherapy in Advanced Renal Cell Carcinoma from a Multicenter Retrospective Cohort Study by the Spanish Genitourinary Oncology Group." BMC Cancer 25, no. 1 (2025): 1835. https://doi.org/10.1186/s12885-025-15264-9.

MLA (9th ed.) Citation

N, Fernández-Díaz, et al. "Real-world Evidence of Nivolumab Monotherapy in Advanced Renal Cell Carcinoma from a Multicenter Retrospective Cohort Study by the Spanish Genitourinary Oncology Group." BMC Cancer, vol. 25, no. 1, 2025, p. 1835, https://doi.org/10.1186/s12885-025-15264-9.